Trastuzumab Deruxtecan in Non-Small-Cell Lung Cancer. Reply

Bob T. Li; Egbert F. Smit; Pasi A. Jänne

doi:10.1056/NEJMc2202305

Trastuzumab Deruxtecan in Non-Small-Cell Lung Cancer. Reply

Bob T. Li
, Egbert F. Smit
, Pasi A. Jänne

Memorial Sloan-Kettering Cancer Center
Netherlands Cancer Institute
Dana-Farber Cancer Institute

Research output: Contribution to journal › Letter › Academic › peer-review

26 Downloads (Pure)

Original language	English
Pages (from-to)	1770-1771
Number of pages	2
Journal	The New England journal of medicine
Volume	386
Issue number	18
DOIs	https://doi.org/10.1056/NEJMc2202305
Publication status	Published - 5 May 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1056/NEJMc2202305

Trastuzumab-deruxtecan-in-non-small-cell-lung-cancer-reply.pdfFinal published version, 402 KBLicence: Taverne

Cite this

@article{4136f24c4c3a48fcbe92dcc945038df9,

title = "Trastuzumab Deruxtecan in Non-Small-Cell Lung Cancer. Reply",

author = "Li, \{Bob T.\} and Smit, \{Egbert F.\} and J{\"a}nne, \{Pasi A.\}",

year = "2022",

month = may,

day = "5",

doi = "10.1056/NEJMc2202305",

language = "English",

volume = "386",

pages = "1770--1771",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "18",

}

TY - JOUR

T1 - Trastuzumab Deruxtecan in Non-Small-Cell Lung Cancer. Reply

AU - Li, Bob T.

AU - Smit, Egbert F.

AU - Jänne, Pasi A.

PY - 2022/5/5

Y1 - 2022/5/5

UR - https://www.scopus.com/pages/publications/85129360015

U2 - 10.1056/NEJMc2202305

DO - 10.1056/NEJMc2202305

M3 - Letter

C2 - 35507496

SN - 0028-4793

VL - 386

SP - 1770

EP - 1771

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 18

ER -

Trastuzumab Deruxtecan in Non-Small-Cell Lung Cancer. Reply

UN SDGs

Access to Document

Other files and links

Cite this